Paper Details

  1. Home
  2. Paper Details

Patient-reported outcomes of bimatoprost for eyelash growth: results from a randomized, double-masked, vehicle-controlled, parallel-group study.

Author: BeddingfieldFrederick C, CarruthersJean, CoxSue Ellen, FagienSteven, WaltJohn G, WengEmily, WirtaDavid

Clinical Trial, Phase IIIA Phase III trial is a trial that further rigorously verifies the efficacy and safety of a new drug or treatment, whose efficacy and safety have been confirmed in a Phase II trial, in a large number of patients, and evaluates whether it is superior to existing treatments.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Bimatoprost ophthalmic solution 0.03% has been associated with increased eyelash prominence.
Paper Details　
Original Abstract of the Article :
Hypotrichosis of the eyelashes may negatively influence an individual's self-perception and appearance. Assessing the impact of treatment from a patient's perspective may be particularly relevant in trials of aesthetic agents. Once-daily dermal (topically applied) administration of bimatoprost ophth...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1177/1090820X13495887

データ提供：米国国立医学図書館（NLM）

Bimatoprost: A Beauty Oasis in the Desert of Eyelash Growth

The desert of eyelash growth can be a challenging landscape for individuals seeking a more prominent and alluring gaze. This research investigates the patient-reported outcomes of bimatoprost, a topical solution used to enhance eyelash length, thickness, and darkness. The authors conducted a randomized, double-masked, vehicle-controlled, parallel-group study to assess the impact of bimatoprost on patient satisfaction. The results showed that bimatoprost significantly increased eyelash prominence, leading to improved self-perception and a greater sense of confidence for participants. This study highlights the importance of considering the patient's perspective in assessing the effectiveness of aesthetic treatments.

Bimatoprost: A Beauty Solution for the Eyelash Desert

The research findings suggest that bimatoprost can effectively enhance eyelash growth, leading to improved self-perception and confidence. This is a significant finding for individuals who have struggled with thin or sparse eyelashes, offering a potentially life-changing solution.

The Beauty of Bimatoprost: A Desert Oasis for Eyelashes

Bimatoprost, like a beautiful oasis in the desert, offers a refreshing solution for those seeking to enhance their eyelashes. The study findings underscore the importance of understanding the patient's experience when evaluating aesthetic treatments. Remember, always consult with a qualified healthcare professional to determine the most appropriate treatment option for your individual needs.

Dr.Camel's Conclusion

This research offers a glimpse into the potential of bimatoprost as a beauty solution for eyelashes. The study's findings highlight the importance of considering patient satisfaction in assessing the effectiveness of aesthetic treatments. Like a traveler discovering a hidden oasis in the desert, bimatoprost may offer a much-needed solution for those seeking to enhance their eyelashes.

Date :
  1. Date Completed 2013-10-21
  2. Date Revised 2016-10-20
Further Info :

Pubmed ID

23873891

DOI: Digital Object Identifier

10.1177/1090820X13495887

Related Literature

Article Analysis
・Effects of bimatoprost ophthalmic
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.